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Abstract 
 
The usage of doxorubicin (DOX) as an anticancer drug in cancer patient may cause 
several side effects. One of that is cardiotoxicity by inducing the expression of nitric oxide 
synthase which may release nitric oxide (NO) resulting reactive oxygen species (ROS) in the 
cardiac. DOX needs to be combined with antioxidant since it could supressed ROS in the 
cardiac and reduce cardiomyopathy. Kelor (Moringa oleifera) is known as the source of 
antioxidant. This study aim to observe the treatment effects of ethanolic extract of kelor 
(EEK) on histopathology profile and concentration of NO in rats cardiac. The result from the 
hematoxylin-eosin staining showed that EEK improved the histopathology profile of rats’ 
cardiac. Compared with the DOX-only treatment, the structure of cardiac muscle cells 
treated by ethanolic extract of kelor is more well-arranged and the cells’ nucleus still visible. 
Concentration of NO was measured by cardiac puncture method. The result showed that 
the concentration of NO was decrease in line with increasing dose levels of EEK in 
combination with DOX. But at rats only given with EEK, the concentration of NO is quite 
high. In conclusion, EEK could be a cochemotherapy agent by reducing the cardiotoxicity 
effect of DOX. 
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INTRODUCTION 
 
Chemotherapy is a cancer treatment 
using chemical compounds to suppress or stop 
the cells proliferation, or cancer cells 
(cytotoxic). Doxorubicin is one of the 
chemotherapeutic agents that are considered 
effective and widely used (Frias, et al., 2009). 
The use of doxorubicin in cancer therapy have 
provided some of the irreversible side effects, 
affect the immune system, hair loss, and 
cardiotoxicity (Bustova, et al., 2009; Frias, et 
al., 2009). A study of 399 patients shows that 
the incidence of heart failure in patients who 
receive large doses of doxorubicin was more 
than 18% (Singal, et al., 2000). Cardiotoxic 
effects can lead to heart failure, inability of the 
heart to pump enough blood throughout the 
body which is due to cardiomyopathy. 
Cardiomyopathy decrease myocardial function 
that caused by several factors, one of them is 
caused by chemotherapeutic agent. Doxorubicin 
can induce the expression of nitric oxide 
synthase (NOs), releases nitric oxide (NO) and 
generates reactive oxygen species (ROS) 
(Fogli, et al., 2004). Therefore, an innovation is 
needed to reduce the cardiotoxic effects of 
doxorubicin. 
Co-chemotherapy is a cancer therapeutic 
strategies by combining a compound with 
chemotherapeutic agents. Compounds or drugs 
may increase the therapeutic efficacy and 
lowering the toxicity of chemotherapeutic 
agents against normal tissue (Sharma, et al., 
2004; Tyagi, et al., 2004).  
Selectioning nature compound as co-
chemotherapy that acts cardioprotector is a 
prospective opportunities in drug development. 
One of the plants could be developed is 
Moringa (Moringa oleifera). Moringa leaves 
are known containing flavonoids, kaempferol 
and quercetin.  
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Kaempferol were reported that have antioxidant 
activity not only in vitro but also in vivo 
(Calderon-Montano, et al., 2011). Previous 
study proved that Moringa leaf extract can 
reduce peroxyl radical activity and superoksil 
(Siddhuraju, 2003). This antioxidant effect may 
suppress the formation of reactive oxygen 
species (ROS) that cause cardiomyopathy. 
This study was conducted to determine 
the effect of ethanolic extract of leaves of 
Moringa (EEK) to the histopathological profiles 
and levels of NO in the heart of doxorubicin-
induced rats. Ultimately, this research is 
expected to be a scientific basis for the 
development of potential drug innovation and 
secure as its application to the prevention of 
cardiovascular disease in patients with cancer 
of the medicinal plants that can be utilized by 
the public. 
 
MATERIALS AND METHODS 
 
Plant collection and identification  
Moringa leaves was obtained from 
Nologaten, Sleman, Yogyakarta. Moringa 
leaves was determinated in Department of 
Pharmaceutical Biology, Faculty of Pharmacy, 
University of Gadjah Mada. Moringa leaves are 
cleaned by washing with water and dried with 
aerated in an open space without being exposed 
to direct sunlight. Continued drying in the oven 
with a maximum temperature of 70˚C. After 
dry, leaves was blended, sieved with a sieve 
size of B40 to obtain a homogeneous powder 
size.  
The powder was extracted by maceration 
method with 70% ethanol. Comparison of 
powder with solvent was 1:10. The extract 
obtained then concentrated using a rotary 
evaporator until the moisture content is less 
than 10%. 
 
Identification of Flavonoids  
 Identification of flavonoid was done 
qualitatively by thin layer chromatography 
(TLC). Moringa leaf extract was dissolved in 
70% ethanol and splatted to stationary phase 
silica gel GF 254 using a capillary tube, after 
that the development of the mobile phase 
Butanol: Acetic Acid: Water (3:1:1) was done. 
Spot detection was done by observation under 
visible light, UV light 254 nm, and 366 nm. 
Spray reagent used was Aluminum Chloride. 
 
 
Animal 
Twenty five female Sprague Dawley 
rats, old about 60 days, weight about 100 grams 
obtained from the Animal-Testing Breeding 
Unit UGM. Rats were placed in separate cages 
at temperature of 28-32˚C, 98% relative 
humidity and light set with 12 hours of light 
and 12 hours of darkness in the ventilated room. 
Rats fed pellets and drinked water ad libitum. 
Rats was adapted in a cage trial of 
Pharmacology and Toxicology Laboratory of 
the Faculty of Pharmacy UGM, Yogyakarta for 
one week before being given treatment. Body 
weight of rats weighed every day during the 
experiment. 
 
In Vivo Experimental Design 
Animal tests were grouped into 5 groups 
and the number of rat in each group was 5. 
Group I was given DOX at 4.67 mg/kgBW 
intraperitoneally once a week, on days 1 and 8. 
Group II was given DOX at 4.67 mg/kg 
intraperitoneally twice a week on days 1 and 8, 
and EEK dose of 500 mg/kgBW were orally 
every day for 2 weeks to on days 1-14. Group 
III was given DOX at 4.67 mg/kgBW 
intraperitoneally twice a week on days 1 and 8, 
and EEK dose of 1000 mg/kgBW were orally 
every day for 2 weeks on days 1-14. Group IV 
was given EEK at 1000 mg/kgBW in the 
solvent CMC-Na 0.5% orally. Group V as a 
group without treatment. All groups were 
treated daily for 14 days.  On 15
th
 day, heart rats 
was taken by surgery to determined cardiac 
histopathology profiles by hematoxylin and 
eosin reagent and measured the amount of NO 
by Griess reagent. 
Determination of cardiac histopatho-
logical profile was done by attaching the heart 
tissue in paraffin then cut and placed on object 
glass. The tissue was given hematoxylin and 
eosin reagent and observed using light 
microscopy. Determination of the amount of 
NO in the heart was done by enzymatic 
reactions that convert nitrate to nitrite using 
nitrate reductase. This reaction is followed by 
colorimetric detection of nitrate with colored 
azo product of the Griess reaction. The 
absorbance products were measured at 533 nm 
wavelength light. 
 
Statistical Analysis 
The results before and after the 
experiment were analyzed by one-way ANOVA 
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method followed by the analysis of One-
Sample Kolmogorov-Smirnov Test and Post 
Hoc Test. 
 
RESULT AND DISCUSSION 
 
Cardiac Hystopathology   
In group I (Fig. 1A), there are heart 
muscle damage characterized by the number of 
cells without nuclei and hypertrophy cells. In 
addition, it appears that occured erythrocyte 
extravasation because the blood vessel is not 
intact. The composition of the cell is 
disorganized and both of nuclei and cells size is 
not uniform. More regularly of cardiac muscle 
structure cells are demonstrated in groups II and 
III (Fig. 1B and 1C). Cells still have the nuclei 
and the size of each cells and nucleus nearly 
uniform. This suggests that the EEK able to 
repair heart muscle cells damaged in rats induce 
doxorubicin, dose dependent. Cardiac 
histopathology profil shown slightly bad in 
group IV (Fig. 1D) because many cells missed 
nucleus. Probably, this condition due to the 
EEK treatment was combined by DOX with 
dose 1000 mg/kgBW is too high. Cardiac 
histopathological profile looks normally in 
group V (Fig. 1E). The size of each cell and 
nucleus nearly uniform, many cells have 
nucleus, did not happen erythrocytes 
extravasation, and blood vessel walls remain 
intact. 
 
Scoring Level of Cardiac Muscle Damage 
The qualitative profile of cardiac 
histopathology then was analyzed semi-
quantitatively by scoring the level of cardiac 
muscle damage. The more severe the damage, 
the higher the score (Table 1). The score 
showed that there is no significant difference 
between the group treated EEK 500mg/kgBW  
and 1000mg/kgBW. This suggests that the 
range  of  doses  used  is  not  wide  enough,  so 
it  can  not  be  determined  the  optimal  dose  
for  EEK  to  protect  cardiac  tissue  from 
damage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cardiac histopathology profile caused by doxorubicin and EEK. The heart of animal test were 
removed during necropsy, and the paraffin preparate of mamae were made to be stained by Hematoxylin 
Eosin staining as decribed in the methods. Pictures shows the preparate of mammae on group treated 
with (A) Dox, (B) Dox+EEK 500mg/KgBW, (C) Dox+EEK 1000 mg/kgBW, (D) EEK 1000mg/kgBW, (E) 
control. Arrow (         ) shows the damage of cardiac muscle. 
 
(B) (A) 
(E) (D) (C) 
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Table 1. The comparison ofthe antiradical activity of extracts 
Group Score Mean 
I 
+3 
+4 
+3 
+3 
+2 
 
 
3* 
II 
+1 
0 
+2 
+1 
+1 
 
 
1 
 
 
III 
0 
+1 
0 
0 
+1 
 
 
0.4 
IV 
0 
0 
0 
0 
0 
 
 
0 
V 
0 
0 
0 
0 
0 
 
 
0 
(*) significantly different with control 
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